SCHEMBL5328866

SCHEMBL5328866

CC(=O)NC1=CC(=O)C(NCC(=O)O)=C(C)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.42
S100A4 P26447 1/20 0.39
CDC25A P30304 1/20 0.36
IDO1 P14902 1/20 0.34
MEN1 O00255 2/20 0.33
RAB9A P51151 2/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 1/20 0.33
PTPRB P23467 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NPC1 O15118 1/20 0.33
MALT1 Q9UDY8 1/20 0.32
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
TDP2 O95551 1/20 0.31
G6PD P11413 1/20 0.31
PAX8 Q06710 1/20 0.31
HKDC1 Q2TB90 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5328420 0.81 TDP1 (0.41) TDP1S100A4IDO1MEN1RAB9A
SCHEMBL5329038 0.80 TDP1 (0.40) TDP1S100A4IDO1MEN1RAB9A
SCHEMBL14386783 0.71 TDP1 (0.49) TDP1S100A4IDO1MEN1RAB9A
SCHEMBL5330070 0.70 TDP1 (0.47) TDP1S100A4CDC25AIDO1MEN1
SCHEMBL7898077 0.67 NSD2 (0.40) TDP1S100A4CDC25AIDO1MEN1
SCHEMBL11241564 0.66 TDP1 (0.42) TDP1S100A4IDO1MEN1RAB9A
SCHEMBL21141270 0.66 MALT1 (0.37) TDP1CDC25ARAB9AKMT2AMALT1
SCHEMBL28654605 0.63 TDP1 (0.46) TDP1S100A4IDO1MEN1RAB9A
SCHEMBL11760216 0.62 SMN1; SMN2 (0.57) TDP1MEN1RAB9AKMT2AHPGD
SCHEMBL8653625 0.62 RAB9A (0.72) TDP1S100A4CDC25AIDO1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO claimed
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO disclosed